David Adams, PhD
	
					
David Adams, PhD
						
	PhD
	Duke University Medical Center
	
	Box 3079
	
	Durham, 
	NC
	USA
	27710
	
	Papers:
	289 - Poster Session A 
	Use of SRC pathway activation in predicting dasatinib activity in ovarian cancer 
	
